New era in gene therapy: end of the beginning

被引：0

作者：

Morishita, Ryuichi ^{[1
]}

机构：

[1] Osaka Univ, Grad Sch Med, Div Clin Gene Therapy, Suita, Osaka 5650871, Japan

来源：

EXPERT OPINION ON BIOLOGICAL THERAPY | 2015年 / 15卷 / 03期

关键词：

ALIPOGENE TIPARVOVEC;

D O I：

10.1517/14712598.2015.1018002

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：309 / 310

页数：2

共 6 条

[1] Effect of Alipogene Tiparvovec (AAV1-LPLS447X) on Postprandial Chylomicron Metabolism in Lipoprotein Lipase-Deficient Patients [J].

Carpentier, Andre C. ;

Frisch, Frederique ;

Labbe, Sebastien M. ;

Gagnon, Rene ;

de Wal, Janneke ;

Greentree, Stephen ;

Petry, Harald ;

Twisk, Jaap ;

Brisson, Diane ;

Gaudet, Daniel .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05) :1635-1644

[2]

Deev R V, 2014, Angiol Sosud Khir, V20, P38

[3] Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial [J].

Gaudet, D. ;

Methot, J. ;

Dery, S. ;

Brisson, D. ;

Essiembre, C. ;

Tremblay, G. ;

Tremblay, K. ;

de Wal, J. ;

Twisk, J. ;

van den Bulk, N. ;

Sier-Ferreira, V. ;

van Deventer, S. .

GENE THERAPY, 2013, 20 (04) :361-369

[4] ALIPOGENE TIPARVOVEC FOR THE TREATMENT OF LIPOPROTEIN LIPASE DEFICIENCY [J].

Haddley, K. .

DRUGS OF TODAY, 2013, 49 (03) :161-170

[5]

Santos RD, 2015, ARTERIOSCLER THROMB

[6] Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European Union [J].

Ylae-Herttuala, Seppo .

MOLECULAR THERAPY, 2012, 20 (10) :1831-1832

← 1 →